← Eichor
Study identifier: NCT05780099 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Prospective Observational Study to Characterize Patients Treated at Internal Medicine Clinics

Condition: Respiratory Disease · Cardiovascular Diseases · Infectious Disease  ·  Sponsor: IRCCS San Raffaele

PhaseN/A
Planned participants50000
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Patients referred to internal medicine wards are becoming increasingly complex and fragile. Despite deep knowledge of their specific disorders, steps are required to improve overall management of their acute and chronic conditions. The main objective of the study is to identify demographic, clinical, laboratory and radiological markers of disease severity and activity in patients with diseases treated at general medicine wards (respiratory disease, immune-mediated disease, sepsis, metabolic disease, rare disease, frailty, pregnancy pathology) in order to improve their diagnosis, monitoring and treatment processes.

This description comes directly from the study's public registry record.

Talk to the study team

Patrizia Rovere Querini, PhD, MD  ·  +390226436095  ·  rovere.patrizia@hsr.it

Rebecca De Lorenzo, MD  ·  +390226433065  ·  delorenzo.rebecca@hsr.it

Always discuss trial participation with your own doctor first.

Locations (2)

Ospedale San RaffaeleMilan, ItalyRecruiting
San Raffaele HospitalMilan, ItalyRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05780099